Hybrid IMRT for Treatment of Cancers of the Lung and Esophagus

International Journal of Radiation Oncology Biology Physics

Volumn 71, Issue 5, 2008, Pages 1408-1418

  Mayo, Charles S ^a   Urie, Marcia M ^a,b   Fitzgerald, Thomas J ^a,b   Ding, Linda ^a   Lo, Yuan Chyuan ^a   Bogdanov, Madeleine ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b Quality Assurance Review Center   (United States)

Author keywords

Esophageal cancer; Intensity modulated radiation therapy; Lung cancer

Indexed keywords

PHYSICAL THERAPY; REDUCTION; THREE DIMENSIONAL;

DOSE DEVIATIONS; DOSE DISTRIBUTIONS; DOSE LEVELS; DOSE--VOLUME HISTOGRAMS; ESOPHAGEAL CANCER; FIELD CALCULATIONS; GENERALIZED EQUIVALENT UNIFORM DOSE; HYBRID TECHNIQUES; INTENSITY-MODULATED RADIATION THERAPY; INTRAFRACTION MOTION; LOW-DOSE; LUNG CANCER; MEAN LUNG DOSE; PLANNING TARGET VOLUME; PLANNING TARGET VOLUMES; TREATMENT PLANNING;

BIOLOGICAL ORGANS;

ADULT; AGED; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; DOSIMETRY; ESOPHAGUS CANCER; FEMALE; HUMAN; INTENSITY MODULATED RADIATION THERAPY; IRRADIATION; LUNG CANCER; LUNG COMPLICATION; LUNG VOLUME; MALE; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; TREATMENT OUTCOME;

ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED; RETROSPECTIVE STUDIES; TUMOR BURDEN;

EID: 47149083332     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2007.12.008     Document Type: Article

References (32)

1. Palta J.R., Deye J.A., Ibbott G.S., et al. Credentialing of institutions for IMRT in clinical trials. Int J Radiat Oncol Biol Phys 59 (2004) 1257-1259
2. Advanced Technology Consortium. Available at http://atc.wustl.edu/home/NCI/NCI_IMRT_Guidelines.html. Accessed January 2007.
3. Allen A.M., Czerminska M., Janne P.A., et al. Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma. Int J Radiat Oncol Biol Phys 65 (2006) 640-645
4. Tucker L., Liu H., and Wang S. Dose-volume modeling of the risk of postoperative pulmonary complications among esophageal cancer patients treated with concurrent chemoradiotherapy followed by surgery. Int J Radiat Oncol Biol Phys 66 (2006) 754-761
5. Mayo C.S., Urie M.M., and Fitzgerald T.J. Hybrid IMRT plans-concurrently treating conventional and IMRT beams for improved breast irradiation and reduced planning time. Int J Radiat Oncol Biol Phys 61 (2005) 922-932
6. Coolens C., Evans P.M., Seco J., et al. The susceptibility of IMRT dose distributions to intrafraction organ motion: An investigation into smoothing filters derived from four dimensional computed tomography data. Med Phys 33 (2006) 2809-2818
7. Nioutsikou E, JRN Symonds-Tayler, et al. Quantifying the effect of respiratory motion on lung tumour dosimetry with the aid of a breathing phantom with deforming lungs. Phys Med Biol 2006;51:3359-3374.
8. Schwarz M., Van der Geer J., Van Herk M., et al. Impact of geometrical uncertainties on 3D CRT and IMRT dose distributions for lung cancer treatment. Int J Radiat Oncol Biol Phys 65 (2006) 1260-1269
9. Duan J., Shen S., Fiveash J.B., et al. Dosimetric and radiobiological impact of dose fractionation on respiratory motion induced IMRT delivery errors: A volumetric dose measurement study. Med Phys 33 (2006) 1380-1387
10. Flampouri S., Jiang S.B., Sharp G.C., et al. Estimation of the delivered patient dose in lung IMRT treatment based on deformable registration of 4D-CT data and Monte Carlo simulations. Phys Med Biol 51 (2006) 2763-2779
11. Keall P., Vedam S., George R., et al. The clinical implementation of respiratory-gated intensity-modulated radiotherapy. Med Dosim 31 (2006) 152-162
12. Vanderstraeten B., Reynaert N., Paelinck L., et al. Accuracy of patient dose calculation for lung IMRT: A comparison of Monte Carlo, convolution/superposition, and pencil beam computations. Med Phys 33 (2006) 3149-3164
13. Papanikolaou N., Battista J., Boyer A., et al. Tissue inhomogeneity corrections for megavoltage photon beams (AAPM Report No. 85). Task Group 65 of the Radiation Therapy Committee of the American Association of Physicists in Medicine (2004), Medical Physics, Madison, WI
14. Paelinck L., Reynaert N., Thierens H., et al. Experimental verification of lung dose with radiochromic film: Comparison with Monte Carlo simulations and commercially available treatment planning systems. Phys Med Biol 50 (2005) 2055-2069
15. Jeraj R., Keall P.J., and Siebers J.V. The effect of dose calculation accuracy on inverse treatment planning. Phys Med Biol 47 (2002) 391-407
16. Mayo C.S., and Urie M. Eclipse IMRT-a practical treatment planning guide. Franklin, MA: KnowNexus (2004)
17. Wu Q., Mohan R., Niemierko A., and Schmidt-Ullrich R. Optimization of intensity-modulated radiotherapy plans based on the equivalent uniform dose. Int J Radiat Oncol Biol Phys 52 (2002) 224-235
18. Burman C., Kutcher G.J., Emami B., and Goitein M. Fitting of normal tissue tolerance data to an analytic function. Int J Radiat Oncol Biol Phys 21 (1991) 123-135
19. Chapet O, Khodri M, Jalade P, et al. Potential benefits of using non coplanar field and intensity modulated radiation therapy to preserve the heart in irradiation of lung tumors in the middle and lower lobes. Radiother Oncol 80:333-340.
20. Kwa S.L., Lebesque J.V., Theuws J.C., et al. Radiation pneumonitis as a function of mean lung dose: An analysis of pooled data of 540 patients. Int J Radiat Oncol Biol Phys 42 (1998) 1-9
21. Oetzel D., Schraube P., Hensley F., et al. Estimation of penumonitis risk in three dimensional planning using dose-volume histogram analysis. Int J Radiat Oncol Biol Phys 33 (1995) 455-460
22. Martel M.K., Ten Haken R.K., Hazuka M.B., et al. Dose-volume histogram and 3D treatment planning evaluation of patients with pneumonitis. Int J Radiat Oncol Biol Phys 28 (1994) 575-581
23. Graham M., Purdy J., Emami B., et al. Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLL). Int J Radiat Oncol Biol Phys 45 (1999) 323-329
24. Tsujino K., Hirota S., Endo M., et al. Predictive value of dose-volume histogram parameters for predicting radiation pneumonitis after concurrent chemoradiation for lung cancer. Int J Radiat Oncol Biol Phys 55 (2003) 110-115
25. Steppenwoolde Y., Lebesque J.V., deJaeger K., et al. Comparing different NTCP models that predict the incidence of radiation pneumonitis. Int J Radiat Oncol Biol Phys 55 (2003) 724-735
26. Wang S., Liao Z., Vaporciyan A., et al. Investigation of clinical and dosimetric factors associated with postoperative pulmonary complications in esophageal cancer patients treated with concurrent chemoradiotherapy followed by surgery. Int J Radiat Oncol Biol Phys 64 (2006) 692-699
27. Yorke E.D., Jackson A., Rosenweig K.E., et al. Correlation of dosimetric factors and radiation pneumonitis for non-small cell lung cancer patients in a recently completed dose escalation study. Int J Radiat Oncol Biol Phys 63 (2005) 672-682
28. Hernando M.L., Marks L.B., Bentel G.C., et al. Radiation-induced pulmonary toxicity: A dose-volume histogram analysis in 201 patients with lung cancer. Int J Radiat Oncol Biol Phys 51 (2001) 650-659
29. Schallenkamp J.M., Miller R.C., Brinkmann D.H., et al. Incidence of radiation pneumonitis after thoracic irradiation: Dose-volume correlates. Int J Radiat Oncol Biol Phys 67 (2007) 410-416
30. Kocak Z., Borst G.R., Zeng J., et al. Prospective assessment of dosimetric/physiologic-bases models for predicting radiation pneumonitis. Int J Radiat Oncol Biol Phys 67 (2007) 178-186
31. Chapet O., Fraass B.A., and Haken R.K. Multiple fields may offer better esophagus sparing without increased probablility of lung toxicity in optimized IMRT of lung tumors. Int J Radiat Oncol Biol Phys 65 (2006) 255-265
32. Bortfeld T., and Paganetti H. The biologic relevance of daily dose variations in adaptive treatment planning. Int J Radiat Oncol Biol Phys 65 (2006) 899-906